Search Within

Michael John Mauro

Formats
  1. Meeting Abstract (187)
  2. Journal Article (66)
  3. Review (7)
  4. Correspondence (4)
  5. Research Letter (3)
  6. Book Section (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Adult Leukemia (272)
  2. Center for Hematologic Malignancies (272)
  3. Department of Medicine (272)
  4. Hematologic Malignancies, Division of (272)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Raajit Rampal (12)
  2. Ellin Berman (8)
  3. Eytan Stein (8)
  4. Martin Tallman (7)
  5. Amber King (6)
  6. Andriy Derkach (6)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (26)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Journal of Clinical Oncology (22)
  4. Haematologica (21)
  5. Leukemia (11)
  6. American Journal of Hematology (8)

More Publications

Publishers
  1. American Society of Hematology (101)
  2. Elsevier Inc. (47)
  3. American Society of Clinical Oncology (22)
  4. Ferrata Storti Foundation (21)
  5. Nature Publishing Group (11)
  6. John Wiley & Sons, Inc. (8)

More Publishers

Results (272)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A matching-adjusted indirect comparison of asciminib versus ponatinib, nilotinib and dasatinib in chronic phase chronic myeloid leukemia patients after ≥2 tyrosine kinase inhibitors
    Meeting Abstract

    Atallah, E. L.; Maheshwari, V.; Mauro, M. J.; Boquimpani, C.; Rea, D.; Hochhaus, A.; Minami, Y.; Saini, L.; Corbin, R.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Management of chronic myeloid leukemia in children and young adults
    Review

    Ford, M.; Mauro, M.; Aftandilian, C.; Sakamoto, K. M.; Hijiya, N.
    Current Hematologic Malignancy Reports (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era
    Meeting Abstract

    Vaughn, J. L.; Devlin, S. M.; Berman, E.; Mauro, M. J.; Papadopoulos, E. B.; Perales, M. A.; Tallman, M.; Giralt, S. A.; Gyurkocza, B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
    Review

    García-Gutiérrez, V.; Breccia, M.; Jabbour, E.; Mauro, M.; Cortes, J. E.
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukaemia: Final 5-year results from the BFORE trial
    Meeting Abstract

    Milojkovic, D.; Brümmendorf, T. H.; Cortes, J. E.; Gambacorti-Passerini, C.; Clark, R. E.; Le Coutre, P.; García-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Patient-reported functional outcomes in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors
    Journal Article

    Schoenbeck, K. L.; Atallah, E.; Lin, L.; Weinfurt, K. P.; Cortes, J.; Deininger, M. W. N.; Kota, V.; Larson, R. A.; Mauro, M. J.; Oehler, V. G.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee
    Journal Article

    Januzzi, J. L.; Garasic, J. M.; Kasner, S. E.; McDonald, V.; Petrie, M. C.; Seltzer, J.; Mauro, M.; Croce, K.; Berman, E.; Deininger, M.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with chronic myeloid leukemia: Poor outcomes for patients with comorbidities, older age, advanced phase disease, and those from low-income countries: An update of the candid study
    Meeting Abstract

    Pagnano, K. B.; Kok, C. H.; Mauro, M. J.; Cortes, J. E.; Evans, N.; Jiang, Q.; Milojkovic, D.; Moiraghi, B.; Nicolini, F. E.; Ongondi, M.; more...
    Blood (2021)

    Fulltext@MSK | Save